President and CEO
Sarepta Therapeutics Inc.
Arizona State University
University of Arizona
Mr. Ingram served as the Chief Executive Officer of Chase Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, and as a member of its Board of Directors from 2015 to 2016.
Most recently, Mr. Ingram served as president of Allergan, Inc. from July 2013 to early 2015 when the company was acquired by Actavis. With the acquisition, Mr. Ingram assumed the role of special advisor on the executive leadership team at Actavis. He also served as executive vice president and president, Europe, Africa and Middle East from August 2010 to June 2013, and executive vice president, chief administrative officer, and secretary from October 2006 to July 2010, where he led Allergan's Global Legal Affairs, Compliance, Internal Audit and Internal Controls, Human Resources, Regulatory Affairs and Safety, and Global Corporate Affairs and Public Relations departments.
Mr. Ingram served as general counsel from January 2001 to June 2009 and as secretary and chief ethics officer from July 2001 to July 2010. He joined Allergan in 1996 as senior attorney and chief litigation counsel. Prior to joining Allergan, he was an attorney at Gibson, Dunn & Crutcher LLP from 1988 to 1996. Mr. Ingram received his Juris Doctor from the University of Arizona in 1988 and his bachelor of science degree from Arizona State University.
Chase Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company focused on the development and commercialization of improved treatments for neurodegenerative disorders. Chase’s development programs, if successful, will profoundly improve the symptomatic treatment of Alzheimer's disease. Chase Pharmaceuticals is led by industry veterans who have an extensive track record in developing and successfully launching life-changing medicines.
Pacific Life Responsibilities
Mr. Ingram serves as a director of Pacific Mutual Holding Company, and serves on the Compensation and Personnel Committee, the Governance and Nominating Committee, and the Member Interests Committee.